| BCBS New Mexico Medical Policies | Nonwearable Automatic External Defibrillators | 2026-04-01 |
| BCBS New Mexico Medical Policies | Ocrelizumab or Ocrelizumab and Hyaluronidase-ocsq | 2026-04-01 |
| BCBS New Mexico Medical Policies | Temporarily Implanted Nitinol Device (iTind) for Benign | 2026-04-01 |
| BCBS New Mexico Medical Policies | Teplizumab-mzwv | 2026-04-01 |
| BCBS New Mexico Medical Policies | Teprotumumab-trbw | 2026-04-01 |
| BCBS New Mexico Medical Policies | Tocilizumab and Associated Biosimilar(s) | 2026-04-01 |
| BCBS New Mexico Medical Policies | Triamcinolone acetonide | 2026-04-01 |
| BCBS New Mexico Medical Policies | Unicondylar Interpositional Spacer as a Treatment of | 2026-04-01 |
| BCBS New Mexico Medical Policies | Vedolizumab | 2026-04-01 |
| Medicare NCD | NCD 110.17 - Anti-Cancer Chemotherapy for Colorectal Cancer - RETIRED | 2026-04-01 |